Curative Biotechnology Inc (CUBT)
$1.18
$0.47
(67.12%)
As on 01-Sep-2026 11:19EDT
Market cap
$8 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-3.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
8,893,876
10 Years Aggregate
CFO
$-3.84 Mln
EBITDA
$-15.85 Mln
Net Profit
$-19.31 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Curative Biotechnology Inc (CUBT)
| 21,750.0 | -9.2 | -26.7 | 13,157.3 | 341.6 | -85.7 | -- |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Curative Biotechnology Inc (CUBT)
| -57.8 | -39.7 | 6.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Curative Biotechnology Inc (CUBT)
|
1.2 | 8.3 | 0.0 | -2.0 | -- | -- | -- | 0.0 |
| 82.7 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 260.3 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 71.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.9 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 107.7 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 363.8 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 538.7 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 583.2 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 353.4 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Curative Biotechnology Inc (CUBT)
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular... degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine; and development agreement with the University of Pennsylvania School of Veterinary Medicine for the development of a metformin-based ophthalmic formulation. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida. Read more
-
President & Executive Chairman
Mr. Paul M. Michaels
-
CEO, CFO, Principal Accounting Officer & General Counsel
Mr. I. Richard Garr Esq., J.D.
-
Headquarters
Palm Beach Gardens, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Curative Biotechnology Inc (CUBT)
What is the current share price of Curative Biotechnology Inc (CUBT) Today?
The share price of Curative Biotechnology Inc (CUBT) is $1.18 (NYSE) as of 01-Sep-2026 11:19 EDT. Curative Biotechnology Inc (CUBT) has given a return of 341.61% in the last 3 years.
What is the current PB & PE ratio of Curative Biotechnology Inc (CUBT)?
Since, TTM earnings of Curative Biotechnology Inc (CUBT) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.02 |
-0.01 |
2024 |
-3.30 |
-2.40 |
2023 |
-4.86 |
-6.12 |
2022 |
-2.15 |
-4.56 |
2021 |
-3.31 |
10.52 |
What is the 52 Week High and Low of Curative Biotechnology Inc (CUBT)?
The 52-week high and low of Curative Biotechnology Inc (CUBT) are Rs 1.99 and Rs 0.00 as of 02-Sep-2026.
What is the market cap of Curative Biotechnology Inc (CUBT)?
Curative Biotechnology Inc (CUBT) has a market capitalisation of $ 8 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Curative Biotechnology Inc (CUBT)?
Before investing in Curative Biotechnology Inc (CUBT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.